Live feed
Filing
SC 13G/A
SC 13G/A0001683168-22-007347·Coeptis Therapeutics Holdings, Inc.
Schedule 13G ownership disclosure
COEPTIS THERAPEUTICS HLDGS I
Security class unavailable · CUSIP: 19207A108
Event date: 2022-10-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,431,691
- Percent of class
- 7.3300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-22-007347
- Form type
- SC 13G/A
- Filer
- Coeptis Therapeutics Holdings, Inc.
- CIK
- CIK 1759186
- Filed
- Nov 07, 2022
- Reporting period
- Oct 28, 2022
- Description
- Schedule 13G beneficial ownership